HRP20070094T3 - Novel 14 and 15 membered-ring compounds - Google Patents
Novel 14 and 15 membered-ring compoundsInfo
- Publication number
- HRP20070094T3 HRP20070094T3 HR20070094T HRP20070094T HRP20070094T3 HR P20070094 T3 HRP20070094 T3 HR P20070094T3 HR 20070094 T HR20070094 T HR 20070094T HR P20070094 T HRP20070094 T HR P20070094T HR P20070094 T3 HRP20070094 T3 HR P20070094T3
- Authority
- HR
- Croatia
- Prior art keywords
- optionally substituted
- hydrogen
- 6alkyl
- groups
- membered
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 11
- 239000001257 hydrogen Substances 0.000 abstract 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical group 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 2
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- -1 -S (O) kC1-6alkyl Chemical group 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Chemical group 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0310962A GB0310962D0 (en) | 2003-05-13 | 2003-05-13 | Novel compounds |
GB0407391A GB0407391D0 (en) | 2004-03-31 | 2004-03-31 | Novel compounds |
PCT/EP2004/005083 WO2004101587A1 (en) | 2003-05-13 | 2004-05-11 | Novel 14 and 15 memberred-ring compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20070094T3 true HRP20070094T3 (en) | 2008-05-31 |
Family
ID=33454579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20070094T HRP20070094T3 (en) | 2003-05-13 | 2007-03-08 | Novel 14 and 15 membered-ring compounds |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070293472A1 (da) |
EP (1) | EP1628989B1 (da) |
JP (1) | JP2006528667A (da) |
AR (1) | AR044304A1 (da) |
AT (1) | ATE348837T1 (da) |
CA (1) | CA2525455A1 (da) |
CL (1) | CL2004001012A1 (da) |
DE (1) | DE602004003809T2 (da) |
DK (1) | DK1628989T3 (da) |
ES (1) | ES2278319T3 (da) |
HR (1) | HRP20070094T3 (da) |
PL (1) | PL1628989T3 (da) |
PT (1) | PT1628989E (da) |
SI (1) | SI1628989T1 (da) |
WO (1) | WO2004101587A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
US20080255060A1 (en) * | 2004-05-06 | 2008-10-16 | Sulejman Alihodzic | Ester Linked Macrolides Useful For The Treatment of Microbial Infections |
GB0424958D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
WO2007054295A1 (en) * | 2005-11-09 | 2007-05-18 | Glaxo Group Limited | New 4*-substituted erythromycin derivative |
GB0424961D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
JP2008540503A (ja) | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用なエーテル結合マクロライド |
EP1945652A1 (en) * | 2005-11-09 | 2008-07-23 | Glaxo Group Limited | Macrolones |
AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
DK2358379T3 (da) | 2008-10-24 | 2016-03-07 | Cempra Pharmaceuticals Inc | Bioforsvar ved anvendelse af triazolholdige macrolider |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
AU2010292010B2 (en) | 2009-09-10 | 2016-01-07 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
DK2571506T3 (da) * | 2010-05-20 | 2017-08-28 | Cempra Pharmaceuticals Inc | Fremgangsmåder til fremstilling af makrolider og ketolider og mellemprodukter dertil |
EP2613630A4 (en) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES |
WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
US9861616B2 (en) | 2013-03-14 | 2018-01-09 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4180654A (en) * | 1978-01-03 | 1979-12-25 | Pfizer Inc. | 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate |
US4512982A (en) * | 1984-04-13 | 1985-04-23 | Pfizer Inc. | 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method |
US4686207A (en) * | 1985-11-12 | 1987-08-11 | Abbott Laboratories | Erythromycin A 11,12-carbonates and method of use |
IL93936A (en) * | 1989-03-28 | 1994-06-24 | Abbott Lab | History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them |
WO1996034007A1 (es) * | 1995-04-27 | 1996-10-31 | Laboratorios Aranda, S.A. De C.V. | Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen |
PT922050E (pt) * | 1996-05-07 | 2003-12-31 | Abbott Lab | Derivados de 3-descladinose-2,3-anidroeritromicina |
EP0895999A1 (en) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
GB0025688D0 (en) * | 2000-10-19 | 2000-12-06 | Glaxo Group Ltd | Macrolides |
WO2003014136A1 (en) * | 2001-08-08 | 2003-02-20 | Taisho Pharmaceutical Co., Ltd. | 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME |
GB0127349D0 (en) * | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
-
2004
- 2004-05-11 SI SI200430216T patent/SI1628989T1/sl unknown
- 2004-05-11 JP JP2006529795A patent/JP2006528667A/ja active Pending
- 2004-05-11 CA CA002525455A patent/CA2525455A1/en not_active Abandoned
- 2004-05-11 CL CL200401012A patent/CL2004001012A1/es unknown
- 2004-05-11 AT AT04732108T patent/ATE348837T1/de not_active IP Right Cessation
- 2004-05-11 DK DK04732108T patent/DK1628989T3/da active
- 2004-05-11 DE DE602004003809T patent/DE602004003809T2/de not_active Expired - Fee Related
- 2004-05-11 PL PL04732108T patent/PL1628989T3/pl unknown
- 2004-05-11 PT PT04732108T patent/PT1628989E/pt unknown
- 2004-05-11 WO PCT/EP2004/005083 patent/WO2004101587A1/en active Application Filing
- 2004-05-11 ES ES04732108T patent/ES2278319T3/es not_active Expired - Lifetime
- 2004-05-11 EP EP04732108A patent/EP1628989B1/en not_active Expired - Lifetime
- 2004-05-11 AR ARP040101609A patent/AR044304A1/es not_active Application Discontinuation
- 2004-05-11 US US10/556,708 patent/US20070293472A1/en not_active Abandoned
-
2007
- 2007-03-08 HR HR20070094T patent/HRP20070094T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT1628989E (pt) | 2007-03-30 |
US20070293472A1 (en) | 2007-12-20 |
JP2006528667A (ja) | 2006-12-21 |
EP1628989B1 (en) | 2006-12-20 |
CA2525455A1 (en) | 2004-11-25 |
SI1628989T1 (sl) | 2007-06-30 |
ES2278319T3 (es) | 2007-08-01 |
EP1628989A1 (en) | 2006-03-01 |
CL2004001012A1 (es) | 2005-03-18 |
PL1628989T3 (pl) | 2007-05-31 |
DE602004003809D1 (de) | 2007-02-01 |
DK1628989T3 (da) | 2007-10-08 |
AR044304A1 (es) | 2005-09-07 |
DE602004003809T2 (de) | 2007-10-11 |
ATE348837T1 (de) | 2007-01-15 |
WO2004101587A1 (en) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20070094T3 (en) | Novel 14 and 15 membered-ring compounds | |
CO5631447A2 (es) | Derivados de heteriarilamida benzocondesada de tieno- piridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos, y metodos pra su uso | |
RS52397B (en) | PYRIDO / 2,1-A / ISOCHINOLINE DERIVATIVES AS DPP-IV INHIBITORS | |
AR040031A1 (es) | Compuestos de pirazol-pirimidina anilina utiles como inhibidores de cinasa y composiciones farmaceuticas que los contienen | |
BR9103433A (pt) | Derivados de 4-benzil-isoxazol | |
DE60017115D1 (de) | Amid-derivate und deren medizinische verwendung | |
ATE287096T1 (de) | Elektrochrome vorrichtung | |
HUP0301671A2 (hu) | 4-Fenil-piridin-származékok, mint neurokinin-1-receptor antagonisták, eljárás az előállításukra és alkalmazásuk | |
PE20051058A1 (es) | Fenilalanina-amidas sustituidas por benzoilo | |
CO4900056A1 (es) | Analogos de indazol sustituidos | |
AR082994A1 (es) | Derivados de pirazina como bloqueadores del canal epitelial de sodio | |
KR950704313A (ko) | 5-아릴인돌 유도체 및 세로토닌(5-ht₁)작용물질로서의 그의 용도(5-arylindole derivatives and their use as serotonin(5-ht₁)agonists) | |
CA2251636A1 (en) | Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle | |
ATE282614T1 (de) | Phenylharnstoff und phenylthioharnstoffderivate | |
AR049269A1 (es) | Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas. | |
CA2487542A1 (en) | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | |
CO5290258A1 (es) | Derivados de fenilheteroalquilaminas, proceso para su prepracion y composiciones farmaceuticas que contienen dichos derivados | |
HUP0400810A2 (hu) | Helyettesített 1-oxa-2,8-diaza-spiro[4.5]dec-2-én-származékok, eljárás előállításukra, alkalmazásuk, és az ezeket tartalmazó gyógyszerkészítmények | |
AR035254A1 (es) | Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica | |
PE20030705A1 (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes | |
PE20020599A1 (es) | Derivados de acido amino-furan-2-il-acetico sustituido o de acido amino-tien-2-il-acetico sustituido, procedimiento para su preparacion, medicamentos que los contienen, uso de estos compuestos para la preparacion de medicamentos para el tratamiento d | |
ATE95816T1 (de) | 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung. | |
AR041860A1 (es) | Compuesto macrolido de oxima sustituido en la posicion 4'', procedimiento de preparacion del mismo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende | |
AR044308A1 (es) | Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4", procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
AR044305A1 (es) | Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende |